Elevance Health (NYSE: ELV) withholds 349 shares to cover EVP tax liability
Elevance Health's EVP & Chief Legal Officer, Erin M. Wessling, disposed of 349 shares to cover tax liability on vesting restricted stock. The transactions occurred on September 2 and 3, 2026, at prices of $405.84 and $414.78 per share, respectively. No Rule 10b5-1 trading plan was reported.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and routine, offering little new insight for traders beyond confirming the vesting event.
Market read
Routine insider tax‑withholding transaction; low trading relevance.
What to watch
The withholding indicates the executive's restricted stock is vesting, which could increase future dilution if more shares are issued.
Background
Form 4 filings disclose insider transactions; tax‑withholding sales are common when restricted stock vests.
Ticker impact
EVP & Chief Legal Officer Erin M. Wessling withheld 349 shares to cover tax liability on vesting restricted stock, disclosed via Form 4.
Minimal impact; likely no immediate price movement.
The transaction size is modest relative to market cap and reflects a routine tax payment, not a change in ownership stance.
Market effects
None; the filing does not affect the health insurance sector broadly.
Limited to Elevance Health investors; no regional effect.
Negligible; only a routine insider transaction.
Counterpoint
Even small insider sales can signal lack of confidence; monitor for any pattern of insider disposals.
Key entities
- ExecutiveErin M. Wessling
EVP & Chief Legal Officer of Elevance Health
- CompanyElevance Health
U.S. health insurance provider (ticker ELV)
%252FElevance%252520Health%252520world%252520headquarters%252520By%252520jetcityimage.jpeg&w=3840&q=75)
